抗凝血蛋白的抗凝溶栓机制

被引:4
作者
顾峰
胡宗利
陈国平
胡功铃
解巧利
机构
[1] 重庆大学生物工程学院
关键词
凝血机制; 抗凝血蛋白; 抗凝溶栓机制;
D O I
10.13376/j.cbls/2010.08.001
中图分类号
Q51 [蛋白质];
学科分类号
摘要
自然界中存在着大量具有抗凝溶栓活性的生物大分子,如水蛭素、蚓激酶等。这些生物大分子主要是通过抑制凝血酶及凝血因子活性,水解纤维蛋白或纤溶酶原,或是抑制血小板聚集来达到抗凝溶栓的作用。该文对这些活性物质的抗凝溶栓机制进行综述。
引用
收藏
页码:755 / 760
页数:6
相关论文
共 16 条
[1]   纳豆激酶对兔血管成形术后再狭窄的影响 [J].
龚敏 ;
林涣冰 ;
王茜 ;
徐江平 .
南方医科大学学报, 2008, (09) :1538-1541
[2]   Earthworm fibrinolytic enzyme:anti-tumor activity on human hepatoma cells in vitro and in vivo [J].
ShoichiTakahashi ;
Michiohnamura ;
EikoOkutani ;
KazuakiChayama .
ChineseMedicalJournal, 2007, 120 (10) :898-904
[3]   A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition [J].
Mo, Wei ;
Zhang, Yan-Ling ;
Chen, Hong-Shan ;
Wang, Long-Sheng ;
Song, Hou-Yan .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) :230-237
[4]  
Tissue-Type Plasminogen Activator: A Multifaceted Modulator of Neurotransmission and Synaptic Plasticity[J] . Andre L. Samson,Robert L. Medcalf.Neuron . 2006 (5)
[5]  
Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin‐10 response in human endotoxemia[J] . A. C. J. M.De Pont,A. H. M.Moons,E.De Jonge,J. C. M.Meijers,G. P.Vlasuk,W. E.Rote,H. R.Büller,T.Van Der Poll,M.Levi.Journal of Thrombosis and Haemostasis . 2004 (1)
[6]  
Novel Anticoagulants for the Prevention and Treatment of Venous Thromboembolism[J] . Ansgar Weltermann,Paul A. Kyrle,Sabine Eichinger.Wiener Medizinische Wochenschrift . 2003 (19)
[7]   Dietary supplementation with fermented soybeans suppresses intimal thickening [J].
Suzuki, Y ;
Kondo, K ;
Ichise, H ;
Tsukamoto, Y ;
Urano, T ;
Umemura, K .
NUTRITION, 2003, 19 (03) :261-264
[8]  
Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery[J] . Yasuhiro Suzuki,Kazunao Kondo,Yuji Matsumoto,Bing-Qing Zhao,Kenichi Otsuguro,Tetsuya Maeda,Yoshinori Tsukamoto,Tetsumei Urano,Kazuo Umemura.Life Sciences . 2003 (10)
[9]  
Fibrinogen–Fibrin System Regulators from Bloodsuckers[J] . L. L. Zavalova,A. V. Basanova,I. P. Baskova.Biochemistry (Moscow) . 2002 (1)
[10]   Effect of thrombin inhibitors and a glycoprotein IIb/IIIa receptor antagonist in an ex vivo human experimental thrombosis model [J].
Zokai, K ;
Piazolo, L ;
Harenberg, J .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (05) :531-536